Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Targeting autophagy as a potential therapeutic approach for immune thrombocytopenia therapy.
The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis.
[Immunoregulative effect of Fasudil on encephalomyelitic T cells in experimental autoimmune encephalomyelitis mice].
Effects of vaccination with altered Peptide ligand on chronic pain in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
Crohn's disease: Is there a place for neurological screening?
Demyelinating disease: Important role for KIR4.1 in demyelinating diseases.
Evaluation of reactive Epstein-Barr Virus (EBV) in Iranian patient with different subtypes of multiple sclerosis (MS).
An adaptive clinical trials procedure for a sensitive subgroup examined in the multiple sclerosis context.
Amino Acid Copolymers That Alleviate Experimental Autoimmune Encephalomyelitis In Vivo Interact with Heparan Sulfates and Glycoprotein 96 in APCs.
Mood disorder as the presenting manifestation of demyelination.
RNA sequencing of microglia and monocyte-derived macrophages from mice with experimental autoimmune encephalomyelitis illustrates a changing phenotype with disease course.
Predictors of quality of life in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
Ventricular tachycardia on chronic fingolimod treatment for multiple sclerosis.
Myeloid-derived suppressor cells in immunity and autoimmunity.
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission.
The atypical chemokine receptor ACKR2 suppresses Th17 responses to protein autoantigens.
[Multiple sclerosis and pregnancy].
Spinal anesthesia for cesarean delivery in a woman with neuromyelitis optica.
[Multiple sclerosis: socioeconomic effects and impact on quality of life].
Multiple sclerosis: 7 T MRI reveals cortical lesions associated with disability in MS.
Risk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple Sclerosis.
Schwann cells and their transcriptional network: Evolution of key regulators of peripheral myelination.
Serum sickness reaction with skin involvement induced by bee venom injection therapy.
Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy.
Profilometry: A new statistical framework for the characterization of white matter pathways, with application to multiple sclerosis.

Pages